> top > docs > PubMed:17266026 > annotations

PubMed:17266026 JSONTXT

Annnotations TAB JSON ListView MergeView

c_corpus

Id Subject Object Predicate Lexical cue
T3 62-75 CVCL_5552 denotes MCF10DCIS.com
T4 67-71 D002285 denotes DCIS
T6 67-71 D002285 denotes DCIS
T8 72-75 CHEBI:17905 denotes com
T9 93-97 D002285 denotes DCIS
T11 93-97 D002285 denotes DCIS
T12 93-101 CVCL_5552 denotes DCIS.com
T13 98-101 CHEBI:17905 denotes com
T16 125-149 D002285 denotes ductal carcinoma in situ
T17 125-149 D002285 denotes ductal carcinoma in situ
T22 170-174 PR:000005054 denotes mice
T24 170-174 O89094 denotes mice
T23 170-174 D051379 denotes mice
T25 170-174 10095 denotes mice
T26 199-215 D044584 denotes ductal carcinoma
T27 199-215 D044584 denotes ductal carcinoma
T30 373-382 GO:0009058 denotes formation
T33 386-403 D002278 denotes carcinoma in situ
T34 386-403 D002278 denotes carcinoma in situ
T35 438-447 D002277 denotes carcinoma
T36 438-447 D002277 denotes carcinoma
T38 449-458 CVCL_5552 denotes MCF10DCIS
T39 454-458 D002285 denotes DCIS
T41 454-458 D002285 denotes DCIS
T42 460-463 CHEBI:17905 denotes com
T43 496-501 UBERON:0000119 denotes layer
T44 496-501 UBERON:0022303 denotes layer
T45 524-541 GO:0005604 denotes basement membrane
T46 524-541 UBERON:0005769 denotes basement membrane
T50 571-578 D016212 denotes TGFbeta
T51 571-578 D016212 denotes TGFbeta
T52 647-653 UBERON:0003891 denotes stroma
T53 666-675 D002277 denotes carcinoma
T54 666-675 D002277 denotes carcinoma
T57 743-760 D002278 denotes carcinoma in situ
T58 743-760 D002278 denotes carcinoma in situ
T59 806-815 D002277 denotes carcinoma
T60 806-815 D002277 denotes carcinoma
T61 821-835 D019718 denotes receptor CXCR4
T62 830-835 PR:O08565 denotes CXCR4
T63 830-835 P56491 denotes CXCR4
T64 830-835 Q28553 denotes CXCR4
T65 830-835 PR:000001208 denotes CXCR4
T66 830-835 Q7YS92 denotes CXCR4
T67 830-835 Q9TSQ8 denotes CXCR4
T68 830-835 Q764M9 denotes CXCR4
T69 830-835 Q3LSL6 denotes CXCR4
T70 830-835 Q8HZU0 denotes CXCR4
T71 830-835 PR:P61073 denotes CXCR4
T73 830-835 P61073 denotes CXCR4
T74 830-835 Q28474 denotes CXCR4
T75 830-835 O62747 denotes CXCR4
T76 830-835 P25930 denotes CXCR4
T77 830-835 P56498 denotes CXCR4
T78 830-835 Q8HZU1 denotes CXCR4
T79 830-835 O08565 denotes CXCR4
T80 830-835 Q07FZ4 denotes CXCR4
T81 830-835 P70658 denotes CXCR4
T82 830-835 P79394 denotes CXCR4
T83 830-835 PR:P70658 denotes CXCR4
T84 830-835 P61072 denotes CXCR4
T72 830-835 GO:0038147 denotes CXCR4
T85 911-921 CL:0000182 denotes hepatocyte
T86 911-935 GO:0005171 denotes hepatocyte growth factor
T96 911-944 Q00PJ8 denotes hepatocyte growth factor receptor
T97 911-944 P08581 denotes hepatocyte growth factor receptor
T98 911-944 Q108U6 denotes hepatocyte growth factor receptor
T99 911-944 Q2QLC0 denotes hepatocyte growth factor receptor
T100 911-944 Q2QLE0 denotes hepatocyte growth factor receptor
T101 911-944 A0M8S8 denotes hepatocyte growth factor receptor
T102 911-944 Q2IBA6 denotes hepatocyte growth factor receptor
T103 911-944 Q07E48 denotes hepatocyte growth factor receptor
T104 911-944 PR:000010335 denotes hepatocyte growth factor receptor
T105 911-944 Q09YN5 denotes hepatocyte growth factor receptor
T106 911-944 P16056 denotes hepatocyte growth factor receptor
T107 911-944 Q09YI9 denotes hepatocyte growth factor receptor
T108 911-944 A0M8R7 denotes hepatocyte growth factor receptor
T109 911-944 Q07DZ1 denotes hepatocyte growth factor receptor
T110 911-944 Q2IBF2 denotes hepatocyte growth factor receptor
T111 911-944 Q2IBC0 denotes hepatocyte growth factor receptor
T112 911-944 Q07E01 denotes hepatocyte growth factor receptor
T113 911-944 P97523 denotes hepatocyte growth factor receptor
T114 911-944 Q07E37 denotes hepatocyte growth factor receptor
T115 911-944 Q07DY1 denotes hepatocyte growth factor receptor
T116 911-944 Q09YH7 denotes hepatocyte growth factor receptor
T117 911-944 Q75ZY9 denotes hepatocyte growth factor receptor
T118 911-944 Q2QLA9 denotes hepatocyte growth factor receptor
T119 911-944 Q09YL1 denotes hepatocyte growth factor receptor
T120 911-944 Q09YK0 denotes hepatocyte growth factor receptor
T121 911-944 Q2QL89 denotes hepatocyte growth factor receptor
T122 911-944 Q07DV8 denotes hepatocyte growth factor receptor
T123 911-944 Q2QLG5 denotes hepatocyte growth factor receptor
T124 911-944 Q2QLF1 denotes hepatocyte growth factor receptor
T125 911-944 Q2IBG7 denotes hepatocyte growth factor receptor
T126 911-944 Q2IBD8 denotes hepatocyte growth factor receptor
T128 911-944 Q2QLH6 denotes hepatocyte growth factor receptor
T129 911-944 Q07E24 denotes hepatocyte growth factor receptor
T130 911-944 Q769I5 denotes hepatocyte growth factor receptor
T131 911-944 A1X150 denotes hepatocyte growth factor receptor
T127 911-944 D019859 denotes hepatocyte growth factor receptor
T137 947-950 CHEBI:32644 denotes met
T140 952-965 CVCL_5552 denotes MCF10DCIS.com
T141 957-961 D002285 denotes DCIS
T143 957-961 D002285 denotes DCIS
T145 962-965 CHEBI:17905 denotes com
T146 1013-1023 UBERON:0000483 denotes epithelium
T147 1028-1034 UBERON:0003891 denotes stroma
T150 1057-1074 D002278 denotes carcinoma in situ
T151 1057-1074 D002278 denotes carcinoma in situ
T152 1099-1108 D002277 denotes carcinoma
T153 1099-1108 D002277 denotes carcinoma
T154 1183-1189 UBERON:0003891 denotes stroma
T155 1205-1215 UBERON:0000483 denotes epithelium
T156 1247-1253 UBERON:0003891 denotes stroma
T157 1304-1311 CVCL_K768 denotes c) 2007
T158 1324-1327 UBERON:0035973 denotes Inc

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 153-169 HP_0002721 denotes immune-deficient

UseCases_ArguminSci_Discourse

Id Subject Object Predicate Lexical cue
T1 0-87 DRI_Outcome denotes Dynamic stromal-epithelial interactions during progression of MCF10DCIS.com xenografts.
T2 88-216 DRI_Background denotes MCF10DCIS.com cells form comedo type ductal carcinoma in situ in immune-deficient mice before forming invasive ductal carcinoma.
T3 217-334 DRI_Background denotes As the lesions mature, both stromal and epithelial cells undergo phenotypic changes detected by immunohistochemistry.
T4 335-448 DRI_Background denotes Myofibroblasts are present before the formation of carcinoma in situ and after development of invasive carcinoma.
T5 449-459 DRI_Unspecified denotes MCF10DCIS.
T6 460-570 DRI_Background denotes com lesions develop a myoepithelial layer prior to exhibiting a basement membrane surrounding the ductal mass.
T7 571-676 DRI_Background denotes TGFbeta1 is initially expressed by the epithelial cells but is expressed by stroma in invasive carcinoma.
T8 677-816 DRI_Background denotes Stromal derived factor-1 is detected in epithelial cells in early carcinoma in situ but is produced in stromal cells in invasive carcinoma.
T9 817-951 DRI_Outcome denotes The receptor CXCR4 is expressed by epithelial cells in the xenografts at all times, as is the hepatocyte growth factor receptor c-met.
T10 952-1109 DRI_Outcome denotes MCF10DCIS.com xenografts illustrate the dynamic interplay of epithelium and stroma in the development of carcinoma in situ and subsequent invasive carcinoma.
T11 1110-1302 DRI_Approach denotes Although the phenotype of the epithelial cells may be dependent upon the stroma, the malignant epithelium induces the development of the stroma necessary for progression to the invasive stage.
T12 1303-1328 DRI_Unspecified denotes (c) 2007 Wiley-Liss, Inc.

PubMed_ArguminSci

Id Subject Object Predicate Lexical cue
T1 88-216 DRI_Background denotes MCF10DCIS.com cells form comedo type ductal carcinoma in situ in immune-deficient mice before forming invasive ductal carcinoma.
T2 217-334 DRI_Background denotes As the lesions mature, both stromal and epithelial cells undergo phenotypic changes detected by immunohistochemistry.
T3 335-448 DRI_Background denotes Myofibroblasts are present before the formation of carcinoma in situ and after development of invasive carcinoma.
T4 460-570 DRI_Background denotes com lesions develop a myoepithelial layer prior to exhibiting a basement membrane surrounding the ductal mass.
T5 571-676 DRI_Background denotes TGFbeta1 is initially expressed by the epithelial cells but is expressed by stroma in invasive carcinoma.
T6 677-816 DRI_Background denotes Stromal derived factor-1 is detected in epithelial cells in early carcinoma in situ but is produced in stromal cells in invasive carcinoma.
T7 817-951 DRI_Outcome denotes The receptor CXCR4 is expressed by epithelial cells in the xenografts at all times, as is the hepatocyte growth factor receptor c-met.
T8 952-1109 DRI_Outcome denotes MCF10DCIS.com xenografts illustrate the dynamic interplay of epithelium and stroma in the development of carcinoma in situ and subsequent invasive carcinoma.
T9 1110-1302 DRI_Approach denotes Although the phenotype of the epithelial cells may be dependent upon the stroma, the malignant epithelium induces the development of the stroma necessary for progression to the invasive stage.